AstraZeneca and Guangzhou Institute of Respiratory Health National Center for Respiratory Medicine Announce Strategic Collaboration

According to AstraZeneca, on April 9, AstraZeneca and the National Center for Respiratory Medicine of the Guangzhou Institute of Respiratory Health officially reached a strategic cooperation. According to the agreement, both parties will strengthen cooperation in basic medicine, translational medicine, and clinical medicine research, and accelerate the development of innovative solutions in the fields of respiratory diseases and major emerging infectious diseases.